Announced FDA acceptance of NDA for new formulation for piflufolastat F 18 PSMA PET imaging agent with a PDUFA date of March 6, 2026
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LNTH:
- Lantheus: Strong Market Position and Growth Potential Justify Buy Rating
- Analysts Spot 3 Strong Buy Russell 2000 Stocks with 100% Upside
- Positive Outlook for Lantheus: Strategic Adjustments and Steady Price Target Support Buy Rating
- Lantheus Completes Acquisition of Life Molecular Imaging
- Lantheus completes acquisition of Life Molecular Imaging